← FDA Drug Approvals (Drugs@FDA)

DEFERASIROX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2022-02-23

Drug application

FDA Application #

ANDA215026

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFERASIROX

Generic name

DEFERASIROX

Active ingredients

DEFERASIROX

Dosage form

GRANULE

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2022-02-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown